Atlas Trials

Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options

Clinical trial NCT00144287 · COMPLETED

Trial details

NCT number
NCT00144287
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
HIV Infections
Start date
2004-05-01
Primary completion
2006-04-01
Enrollment
255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.